close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Spectrum Pharmaceuticals, Inc. - Common Stock (NQ:SPPI)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Spectrum Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
News headline image
CLASS ACTION UPDATE for BLCT, ATVI and SPPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / September 3, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
News headline image
SHAREHOLDER ALERT: ITRM SESN SPPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / September 3, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered... 
From The Law Offices of Vincent Wong
Via AccessWire
Topics Fraud
News headline image
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of JRVR, CRMD and SPPI
NEW YORK, NY / ACCESSWIRE / September 2, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded... 
From The Gross Law Firm
Via AccessWire
News headline image
SPECTRUM ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
CLASS ACTION UPDATE for ATVI, SLQT and SPPI: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / September 2, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.... 
From Levi & Korsinsky, LLP
Via AccessWire
Topics Lawsuit
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LIVE, SLQT and SPPI
NEW YORK, NY / ACCESSWIRE / September 2, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to... 
From The Klein Law Firm
Via AccessWire
Topics Fraud Lawsuit
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Spectrum Pharmaceuticals, Inc. (SPPI) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
News headline image
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
SPPI ALERT: Investors With Substantial Losses Have Opportunity to Lead the Spectrum Pharmaceuticals, Inc. Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – SPPI
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
Have You Lost Money Investing In Spectrum Pharmaceuticals? Securities Class Action Investigation -SPPI Investors Who Have Suffered Financial Losses Encouraged To Contact Kehoe Law Firm, P.C.
PHILADELPHIA, PA / ACCESSWIRE / September 1, 2021 / Kehoe Law Firm, P.C. is investigating whether Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ:SPPI) violated federal securities... 
From Kehoe Law Firm, P.C.
Via AccessWire
Topics Fraud Lawsuit
News headline image
Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Investor Notice: Investigation over Possible Securities Laws Violations ↗
San Diego, CA -- (SBWIRE) -- 08/17/2021 -- Spectrum Pharmaceuticals, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. 
Via SBWire
News headline image
Spectrum Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
News headline image
SPECTRUM ALERT: Bragar Eagel & Squire, P.C. is Investigating Spectrum Pharmaceuticals, Inc. on Behalf of Spectrum Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
News headline image
Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS® (eflapegrastim)
From Spectrum Pharmaceuticals
Via Business Wire
News headline image
Spectrum Pharmaceuticals to Report Second Quarter 2021 Financial Results and Provide Corporate Update
From Spectrum Pharmaceuticals
Via Business Wire
News headline image
Spectrum Pharmaceuticals Presents Poziotinib Data in Patients with Brain Metastases from the ZENITH20 Clinical Trial at 2021 ASCO Annual Meeting
From Spectrum Pharmaceuticals
Via Business Wire
News headline image
Spectrum Pharmaceuticals Announces That the ROLONTIS® (eflapegrastim) Pre-Approval Inspection Has Been Initiated
From Spectrum Pharmaceuticals
Via Business Wire
News headline image
Spectrum Pharmaceuticals to Present Data for Poziotinib in Patients with Brain Metastases at the Upcoming 2021 ASCO Annual Meeting
From Spectrum Pharmaceuticals
Via Business Wire
News headline image
Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences in June
From Spectrum Pharmaceuticals
Via Business Wire
News headline image
Spectrum Pharmaceuticals Reports First Quarter 2021 Financial Results and Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
News headline image
Spectrum Pharmaceuticals to Report First Quarter 2021 Financial Results and Provide Corporate Update
From Spectrum Pharmaceuticals, Inc.
Via Business Wire
News headline image
Spectrum Pharmaceuticals Presents Additional Twice Daily Dosing Data for Poziotinib at the AACR Virtual Meeting 2021
From Spectrum Pharmaceuticals
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today